U.S. PHYSICAL THERAPY INC (USPH) Stock Fundamental Analysis
NYSE:USPH - New York Stock Exchange, Inc. - US90337L1089 - Common Stock - Currency: USD
USPH gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 103 industry peers in the Health Care Providers & Services industry. USPH has only an average score on both its financial health and profitability. While showing a medium growth rate, USPH is valued expensive at the moment.
1. Profitability
1.1 Basic Checks
USPH had positive earnings in the past year.
In the past year USPH had a positive cash flow from operations.
USPH had positive earnings in each of the past 5 years.
Each year in the past 5 years USPH had a positive operating cash flow.
1.2 Ratios
USPH has a better Return On Assets (2.78%) than 62.14% of its industry peers.
With a decent Return On Equity value of 6.60%, USPH is doing good in the industry, outperforming 66.02% of the companies in the same industry.
USPH has a Return On Invested Capital (5.40%) which is in line with its industry peers.
USPH had an Average Return On Invested Capital over the past 3 years of 5.78%. This is below the industry average of 9.71%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.78% | ||
| ROE | 6.6% | ||
| ROIC | 5.4% |
ROA(3y)2.54%
ROA(5y)3.42%
ROE(3y)6.25%
ROE(5y)8.16%
ROIC(3y)5.78%
ROIC(5y)6.77%
1.3 Margins
USPH's Profit Margin of 4.69% is fine compared to the rest of the industry. USPH outperforms 75.73% of its industry peers.
USPH's Profit Margin has declined in the last couple of years.
USPH has a better Operating Margin (10.78%) than 81.55% of its industry peers.
USPH's Operating Margin has declined in the last couple of years.
USPH has a worse Gross Margin (18.74%) than 63.11% of its industry peers.
In the last couple of years the Gross Margin of USPH has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 10.78% | ||
| PM (TTM) | 4.69% | ||
| GM | 18.74% |
OM growth 3Y-9.96%
OM growth 5Y-5.7%
PM growth 3Y-13.05%
PM growth 5Y-8.65%
GM growth 3Y-6.9%
GM growth 5Y-3.92%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), USPH is destroying value.
USPH has more shares outstanding than it did 1 year ago.
USPH has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, USPH has an improved debt to assets ratio.
2.2 Solvency
USPH has an Altman-Z score of 2.09. This is not the best score and indicates that USPH is in the grey zone with still only limited risk for bankruptcy at the moment.
USPH's Altman-Z score of 2.09 is in line compared to the rest of the industry. USPH outperforms 47.57% of its industry peers.
The Debt to FCF ratio of USPH is 2.98, which is a good value as it means it would take USPH, 2.98 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 2.98, USPH is in the better half of the industry, outperforming 77.67% of the companies in the same industry.
A Debt/Equity ratio of 0.32 indicates that USPH is not too dependend on debt financing.
USPH has a Debt to Equity ratio of 0.32. This is in the better half of the industry: USPH outperforms 63.11% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.32 | ||
| Debt/FCF | 2.98 | ||
| Altman-Z | 2.09 |
ROIC/WACC0.64
WACC8.46%
2.3 Liquidity
A Current Ratio of 1.17 indicates that USPH should not have too much problems paying its short term obligations.
USPH has a worse Current ratio (1.17) than 65.05% of its industry peers.
A Quick Ratio of 1.17 indicates that USPH should not have too much problems paying its short term obligations.
USPH's Quick ratio of 1.17 is in line compared to the rest of the industry. USPH outperforms 40.78% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.17 | ||
| Quick Ratio | 1.17 |
3. Growth
3.1 Past
The Earnings Per Share has been growing slightly by 2.82% over the past year.
Measured over the past years, USPH shows a decrease in Earnings Per Share. The EPS has been decreasing by -1.76% on average per year.
The Revenue has grown by 14.30% in the past year. This is quite good.
The Revenue has been growing slightly by 6.85% on average over the past years.
EPS 1Y (TTM)2.82%
EPS 3Y-6.63%
EPS 5Y-1.76%
EPS Q2Q%-5.88%
Revenue 1Y (TTM)14.3%
Revenue growth 3Y10.69%
Revenue growth 5Y6.85%
Sales Q2Q%18.06%
3.2 Future
The Earnings Per Share is expected to grow by 8.71% on average over the next years. This is quite good.
The Revenue is expected to grow by 9.47% on average over the next years. This is quite good.
EPS Next Y0.5%
EPS Next 2Y6.46%
EPS Next 3Y8.71%
EPS Next 5YN/A
Revenue Next Year14.17%
Revenue Next 2Y10.04%
Revenue Next 3Y9.47%
Revenue Next 5YN/A
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 29.39 indicates a quite expensive valuation of USPH.
The rest of the industry has a similar Price/Earnings ratio as USPH.
USPH's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 27.48.
USPH is valuated quite expensively with a Price/Forward Earnings ratio of 25.63.
USPH's Price/Forward Earnings is on the same level as the industry average.
Compared to an average S&P500 Price/Forward Earnings ratio of 36.52, USPH is valued a bit cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 29.39 | ||
| Fwd PE | 25.63 |
4.2 Price Multiples
USPH's Enterprise Value to EBITDA ratio is in line with the industry average.
USPH's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. USPH is cheaper than 64.08% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 20.36 | ||
| EV/EBITDA | 13.01 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
PEG (NY)59.06
PEG (5Y)N/A
EPS Next 2Y6.46%
EPS Next 3Y8.71%
5. Dividend
5.1 Amount
USPH has a Yearly Dividend Yield of 2.36%.
USPH's Dividend Yield is rather good when compared to the industry average which is at 2.51. USPH pays more dividend than 92.23% of the companies in the same industry.
USPH's Dividend Yield is comparable with the S&P500 average which is at 2.34.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.36% |
5.2 History
The dividend of USPH is nicely growing with an annual growth rate of 9.09%!
USPH has paid a dividend for at least 10 years, which is a reliable track record.
USPH has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)9.09%
Div Incr Years4
Div Non Decr Years4
5.3 Sustainability
USPH pays out 80.88% of its income as dividend. This is not a sustainable payout ratio.
USPH's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP80.88%
EPS Next 2Y6.46%
EPS Next 3Y8.71%
74.95
+1.22 (+1.65%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners103.36%
Inst Owner Change0%
Ins Owners1.91%
Ins Owner Change12.64%
Market Cap1.14B
Analysts84.62
Price Target107.3 (43.16%)
Short Float %3.85%
Short Ratio3.23
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.36% |
Yearly Dividend1.76
Dividend Growth(5Y)9.09%
DP80.88%
Div Incr Years4
Div Non Decr Years4
Ex-Date
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.9%
Min EPS beat(2)-7.64%
Max EPS beat(2)9.44%
EPS beat(4)1
Avg EPS beat(4)-2.94%
Min EPS beat(4)-12.54%
Max EPS beat(4)9.44%
EPS beat(8)2
Avg EPS beat(8)-2.74%
EPS beat(12)4
Avg EPS beat(12)-1.8%
EPS beat(16)8
Avg EPS beat(16)1.16%
Revenue beat(2)2
Avg Revenue beat(2)1.44%
Min Revenue beat(2)1.22%
Max Revenue beat(2)1.65%
Revenue beat(4)4
Avg Revenue beat(4)1.02%
Min Revenue beat(4)0.22%
Max Revenue beat(4)1.65%
Revenue beat(8)5
Avg Revenue beat(8)0.21%
Revenue beat(12)6
Avg Revenue beat(12)-0.12%
Revenue beat(16)8
Avg Revenue beat(16)-0.1%
PT rev (1m)0%
PT rev (3m)-2.59%
EPS NQ rev (1m)1.85%
EPS NQ rev (3m)-6.9%
EPS NY rev (1m)-0.83%
EPS NY rev (3m)-3.89%
Revenue NQ rev (1m)-0.12%
Revenue NQ rev (3m)0.26%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.16%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 29.39 | ||
| Fwd PE | 25.63 | ||
| P/S | 1.63 | ||
| P/FCF | 20.36 | ||
| P/OCF | 17.29 | ||
| P/B | 2.29 | ||
| P/tB | N/A | ||
| EV/EBITDA | 13.01 |
EPS(TTM)2.55
EY3.4%
EPS(NY)2.92
Fwd EY3.9%
FCF(TTM)3.68
FCFY4.91%
OCF(TTM)4.33
OCFY5.78%
SpS46.05
BVpS32.74
TBVpS-23.33
PEG (NY)59.06
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.78% | ||
| ROE | 6.6% | ||
| ROCE | 7.14% | ||
| ROIC | 5.4% | ||
| ROICexc | 5.61% | ||
| ROICexgc | 34.54% | ||
| OM | 10.78% | ||
| PM (TTM) | 4.69% | ||
| GM | 18.74% | ||
| FCFM | 7.99% |
ROA(3y)2.54%
ROA(5y)3.42%
ROE(3y)6.25%
ROE(5y)8.16%
ROIC(3y)5.78%
ROIC(5y)6.77%
ROICexc(3y)6.35%
ROICexc(5y)7.3%
ROICexgc(3y)37.05%
ROICexgc(5y)44.29%
ROCE(3y)7.65%
ROCE(5y)8.96%
ROICexcg growth 3Y-11.04%
ROICexcg growth 5Y-7.52%
ROICexc growth 3Y-14.51%
ROICexc growth 5Y-13.29%
OM growth 3Y-9.96%
OM growth 5Y-5.7%
PM growth 3Y-13.05%
PM growth 5Y-8.65%
GM growth 3Y-6.9%
GM growth 5Y-3.92%
F-Score5
Asset Turnover0.59
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.32 | ||
| Debt/FCF | 2.98 | ||
| Debt/EBITDA | 1.64 | ||
| Cap/Depr | 48.54% | ||
| Cap/Sales | 1.42% | ||
| Interest Coverage | 9.96 | ||
| Cash Conversion | 68.67% | ||
| Profit Quality | 170.42% | ||
| Current Ratio | 1.17 | ||
| Quick Ratio | 1.17 | ||
| Altman-Z | 2.09 |
F-Score5
WACC8.46%
ROIC/WACC0.64
Cap/Depr(3y)54.79%
Cap/Depr(5y)61.53%
Cap/Sales(3y)1.47%
Cap/Sales(5y)1.57%
Profit Quality(3y)269.82%
Profit Quality(5y)263.85%
High Growth Momentum
Growth
EPS 1Y (TTM)2.82%
EPS 3Y-6.63%
EPS 5Y-1.76%
EPS Q2Q%-5.88%
EPS Next Y0.5%
EPS Next 2Y6.46%
EPS Next 3Y8.71%
EPS Next 5YN/A
Revenue 1Y (TTM)14.3%
Revenue growth 3Y10.69%
Revenue growth 5Y6.85%
Sales Q2Q%18.06%
Revenue Next Year14.17%
Revenue Next 2Y10.04%
Revenue Next 3Y9.47%
Revenue Next 5YN/A
EBIT growth 1Y12.7%
EBIT growth 3Y-0.34%
EBIT growth 5Y0.76%
EBIT Next Year34.64%
EBIT Next 3Y16.55%
EBIT Next 5YN/A
FCF growth 1Y10.82%
FCF growth 3Y-1.21%
FCF growth 5Y4.7%
OCF growth 1Y13.06%
OCF growth 3Y-0.65%
OCF growth 5Y3.71%